Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 8/20 | 0.52 |
| ▸ | CTSB | P07858 | 5/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.50 |
| ▸ | CTSS | P25774 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | REN | P00797 | 1/20 | 0.50 |
| ▸ | KYNU | Q16719 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24722335 | 0.91 | CTSK (0.60) | CTSKCTSBCTSLCTSSKYNU | |
| SCHEMBL24722407 | 0.90 | ELANE (0.52) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722577 | 0.89 | ELANE (0.52) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722559 | 0.88 | CTSD (0.60) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722711 | 0.87 | CTSK (0.51) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722581 | 0.87 | CTSK (0.51) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722341 | 0.87 | REN (0.60) | ELANECASP3CTSKCTSBCTSD | |
| SCHEMBL24722709 | 0.86 | ELANE (0.49) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL5689424 | 0.86 | CASP3 (0.58) | ELANECASP3CTSKCTSBCTSL | |
| SCHEMBL24722560 | 0.84 | ELANE (0.50) | ELANECASP3CTSKCTSBCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220267699-A1 | PEPTIDE ACETALS FOR STABILISING ENZYMES | BASF SE (DE) | 2022-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267699-A1 | PEPTIDE ACETALS FOR STABILISING ENZYMES | IDE, PEPD, PREP | ELANE 546/4885CASP3 2668/4885CTSK 486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.